Your browser doesn't support javascript.
loading
The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
Montgomery, Karen G; Chang, Jiun-Horng; Gertig, Dorota M; Dite, Gillian S; McCredie, Margaret R; Giles, Graham G; Southey, Melissa C; Hopper, John L; Campbell, Ian G.
Affiliation
  • Montgomery KG; Cancer Genetics Laboratory, Victorian Breast Cancer Research Consortium, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, Victoria, Australia. karen.montgomery@petermac.org
Breast Cancer Res ; 7(3): R353-6, 2005.
Article in En | MEDLINE | ID: mdl-15987430

Full text: 1 Database: MEDLINE Main subject: Acetyltransferases / Breast Neoplasms / Trans-Activators / Oncogene Proteins / Genetic Predisposition to Disease Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans Country/Region as subject: Oceania Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2005 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Acetyltransferases / Breast Neoplasms / Trans-Activators / Oncogene Proteins / Genetic Predisposition to Disease Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans Country/Region as subject: Oceania Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2005 Type: Article Affiliation country: Australia